/주식/ANVS
ANVS

ANVS

USD

Annovis Bio Inc. Common Stock

$1.890-0.060 (-3.077%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.950

고가

$2.029

저가

$1.890

거래량

0.22M

기업 기본 정보

시가총액

46.2M

산업

생명공학

국가

United States

거래 통계

평균 거래량

0.60M

거래소

NYQ

통화

USD

52주 범위

저가 $1.11현재가 $1.890고가 $8.93

관련 뉴스

GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

더 보기
Annovis Announces $6 Million Registered Direct Offering of Common Stock
GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

더 보기
Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment
GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

더 보기
Annovis Appoints Mark Guerin as Chief Financial Officer